| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 17/05/2024 | 13:36 | IH Market News | OpenAI’s Reddit Partnership Boosts Shares by 14%, Microsoft Embraces AMD Chips for AI, and More News | NYSE:GSK | GSK plc |
| 17/05/2024 | 12:00 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NYSE:GSK | GSK plc |
| 07/05/2024 | 07:00 | GlobeNewswire Inc. | BioVersys Announces Expansion of Strategic Collaboration With GSK and Extension of Its Series C Round by CHF 12.3 Million | NYSE:GSK | GSK plc |
| 26/04/2024 | 13:48 | IH Market News | Anglo American Rejects BHP Group’s Offer, Toyota Invests $1.4 Billion in Indiana, and More News | NYSE:GSK | GSK plc |
| 16/03/2024 | 13:00 | Business Wire | Positive RUBY phase III data show potential for Jemperli (dostarlimab-gxly) combinations in more patients with primary advanced or recurrent endometrial cancer | NYSE:GSK | GSK plc |
| 07/03/2024 | 18:00 | Business Wire | GSK Doubles COiMMUNITY Grant Funding, Launches Patient Resources, as Adult Vaccination Rates Begin to Show Promising Rise | NYSE:GSK | GSK plc |
| 05/03/2024 | 18:30 | Edgar (US Regulatory) | Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)). | NYSE:GSK | GSK plc |
| 05/03/2024 | 18:10 | Edgar (US Regulatory) | Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] | NYSE:GSK | GSK plc |
| 29/02/2024 | 12:11 | IH Market News | Shares of WW International Plummet after Oprah Exits, EA Announces Workforce Reduction and Restructuring Plan, and Latest News | NYSE:GSK | GSK plc |
| 15/02/2024 | 12:34 | IH Market News | Cisco Systems Stock Drops 5% Following Restructuring Plan, Berkshire Trims Apple Stake, and Latest News | NYSE:GSK | GSK plc |
| 08/02/2024 | 13:00 | GlobeNewswire Inc. | Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Patients with Early Alzheimer’s Disease | NYSE:GSK | GSK plc |
| 07/02/2024 | 22:01 | GlobeNewswire Inc. | 23andMe Reports Third Quarter Fiscal 2024 Financial Results | NYSE:GSK | GSK plc |
| 07/02/2024 | 13:00 | GlobeNewswire Inc. | FDA Grants Latozinemab Breakthrough Therapy Designation for Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN) | NYSE:GSK | GSK plc |
| 06/02/2024 | 13:00 | Business Wire | GSK’s RSV Vaccine, AREXVY, Accepted Under Priority Review in US for the Prevention of RSV Disease in Adults Aged 50-59 at Increased Risk | NYSE:GSK | GSK plc |
| 31/01/2024 | 12:28 | IH Market News | Walmart’s Stock Split, Elon Musk’s Billion-Dollar Package Revoked, and More | NYSE:GSK | GSK plc |
| 30/01/2024 | 22:39 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:GSK | GSK plc |
| 24/01/2024 | 20:11 | Business Wire | Elegen e GSK firmano un accordo di collaborazione e di licenza per sviluppare ulteriormente la tecnologia produttiva del DNA privo di cellule di Elegen | NYSE:GSK | GSK plc |
| 24/01/2024 | 18:52 | Business Wire | Elegen und GSK unterzeichnen Kooperations- und Lizenzvereinbarung zur Weiterentwicklung der zellfreien DNA-Produktionstechnologie von Elegen | NYSE:GSK | GSK plc |
| 24/01/2024 | 17:37 | Business Wire | Elegen et GSK signent un accord de collaboration et de licence pour continuer le développement de la technologie de production d’ADN acellulaire d’Elegen | NYSE:GSK | GSK plc |
| 24/01/2024 | 14:00 | Business Wire | Elegen and GSK Sign Collaboration and Licensing Agreement to Further Develop Elegen’s Cell-Free DNA Production Technology | NYSE:GSK | GSK plc |
| 19/01/2024 | 22:20 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] | NYSE:GSK | GSK plc |
| 18/01/2024 | 13:49 | Dow Jones News | HilleVax Taps Sean McLoughlin as Chief Operating Officer | NYSE:GSK | GSK plc |
| 17/01/2024 | 12:33 | IH Market News | Wall Street Highlights: Tesla Cuts Prices in Germany, Interactive Brokers Increases Revenue by 17%, and More | NYSE:GSK | GSK plc |
| 17/01/2024 | 10:04 | Dow Jones News | Correction to GSK Article on Tuesday | NYSE:GSK | GSK plc |
| 17/01/2024 | 08:44 | Dow Jones News | GSK Sells Haleon Shares Valued Around $1.24 Billion Through Discounted Placing | NYSE:GSK | GSK plc |
| 16/01/2024 | 18:19 | Dow Jones News | GSK to Sell Haleon Shares Worth Around $1.27 Billion | NYSE:GSK | GSK plc |
| 10/01/2024 | 12:21 | IH Market News | Wall Street Highlights: Tesla Launches Restyled Model 3, VinFast Unveils Pickup Prototype, and More | NYSE:GSK | GSK plc |
| 09/01/2024 | 12:37 | Dow Jones News | Trending: GSK Buys Asthma-Specialist Aiolos Bio For Up To $1.4 Billion | NYSE:GSK | GSK plc |
| 09/01/2024 | 12:12 | IH Market News | Wall Street Highlights: HPE and Juniper Networks in Negotiations, Elliott Invests $1 Billion in Match Group, and More | NYSE:GSK | GSK plc |
| 09/01/2024 | 11:52 | Business Wire | GSK Enters Agreement to Acquire Aiolos Bio | NYSE:GSK | GSK plc |